Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips There’s an argument to be made that all of the recent movement in Orphazyme (NASDAQ: ORPH ) is simply a sign of the times. Even if it isn’t, there’s little reason to invest in ORPH stock now. T...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s an understatement to say recent developments have been a crushing blow for Orphazyme A/S (NASDAQ: ORPH ) stock. Source: Shutterstock Due to the hype surrounding it, shares, which previously were trad...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Denmark-based late-stage biopharmaceutical company Orphazyme (NASDAQ: ORPH ) is tiny, but has been getting lots of attention lately. That’s because ORPH stock is making some outsized moves, and traders wan...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today, investors in Orphazyme (NASDAQ: ORPH ) and ORPH stock have a lot to cheer. Amid a couple important announcements, this biopharma company has gotten a lot of attention of late for its investigatio...
Gainers: Cerevel Therapeutics CERE +113%, Avinger (AVGR) +22%, Translate Bio TBIO +14%, Orphazyme ORPH +11%, Regional Health Properties (RHE) +8%.Losers: DiaMedica Therapeutics DMAC -33%, MediWound MDWD -29%, ReShape Lifescience...
AndrewJohnson/E+ via Getty Images Orphazyme (ORPH) ADRs have added ~18.4% in the pre-market after the company announced 24-month interim results of an open-label extension ((OLE)) trial for arimoclomol in Niemann-Pick disease type C ((NPC)), a rare neurodegenerative diseas...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Short squeeze stocks have been targeted quite a bit lately as Reddit and retail traders tackle them in an effort to push out hedge funds and ramp up prices. Source: Shutterstock As such, it comes as no surprise that...
What Beginners Need to Know About Buying Penny Stocks in 2021 Trading penny stocks in 2021 is all about understanding what to look for when buying small caps. While this may seem self-explanatory, there are a few nuances that many investors don’t consider when making a penny st...
Marin Software Incorporated (MRIN) +63% on new InstaCart Ad Integration.India Globalization Capital (IGC) +22% on Alzheimer’s drug trial update.GTT Communications (GTT) +21%.Aravive, Inc. (ARAV) +20% on early-stage kidney cancer study data.Arcus Biosciences (RCUS) +19%...
Shares of Orphazyme (NASDAQ: ORPH) skyrocketed 24.6% as of the market close on Wednesday after rising as much as 56.6% earlier in the day. The big gain came after the drugmaker announced that Goldman Sachs (NYSE: GS) temporarily increased its stake to 5.58% on Jun. 16, 2021,...
News, Short Squeeze, Breakout and More Instantly...
Orphazyme A/S Company Name:
ORPH Stock Symbol:
NASDAQ Market:
(NewsDirect) hVIVO PLC (AIM:HVO) chief executive Yamin 'Mo' Khan discusses the company's record-breaking financial results in 2023 in an interview with Proactive's Stephen Gunnion. hVIVO announced a 16% year-on-year growth in revenue, reaching £56 million, with an EBITDA margin i...
(NewsDirect) hVIVO chairman Cathal Friel joined Proactive's Stephen Gunnion to discuss the sale of shares in hVIVO PLC by directors, including himself. Friel explained his decision to sell a portion of his shares in hVIVO was to accommodate the high demand from major institutions whil...
(NewsDirect) hVIVO PLC (AIM:HVO) Chief Scientific Officer Andrew Catchpole speaks to Steve Darling from Proactive after the specialist contract research organisation announced it has secured a £6.3 million contract with a biotechnology client for the testing of their antiviral candid...